Catalyst Pharmaceuticals, Inc. (CPRX)
23.16
-0.37
(-1.57%)
USD |
NASDAQ |
Dec 08, 16:00
23.16
0.00 (0.00%)
After-Hours: 07:42
Catalyst Pharmaceuticals Market Cap: 2.847B for Dec. 8, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Collegium Pharmaceutical, Inc. | 1.514B |
| ACADIA Pharmaceuticals, Inc. | 4.527B |
| Amicus Therapeutics, Inc. | 3.039B |
| Rigel Pharmaceuticals, Inc. | 787.77M |
| United Therapeutics Corp. | 20.65B |
Market Cap Related Metrics
| PE Ratio | 13.51 |
| PS Ratio | 5.086 |
| PEG Ratio | 0.2923 |
| Price to Book Value | 3.093 |
| Price to Free Cash Flow | 12.54 |
| Price | 23.16 |
| Earnings Yield | 7.40% |
| PEGY Ratio | 0.2923 |
| Operating PE Ratio | 11.36 |
| Normalized PE Ratio | 13.71 |